keyword
https://read.qxmd.com/read/38703010/onset-and-resolution-of-ovarian-toxicity-with-nirogacestat-treatment-in-females-with-desmoid-tumors-updated-safety-analyses-from-the-defi-phase-3-study
#1
JOURNAL ARTICLE
Elizabeth T Loggers, Rashmi Chugh, Noah Federman, Lee Hartner, Richard F Riedel, Sunny Cho, David Hyslop, Allison Lim, Ana B Oton, Kutluk H Oktay
INTRODUCTION: Nirogacestat is a targeted gamma secretase inhibitor approved in the United States for adults with progressing desmoid tumors. In the phase 3 DeFi study (NCT03785964) of nirogacestat, ovarian toxicity (OT) was identified as a safety signal among females of reproductive potential (FORP). This analysis further describes the incidence, presentation, and resolution of OT. METHODS: Patients were randomized to twice-daily oral nirogacestat (150 mg) or placebo, taken in continuous 28-day cycles...
May 4, 2024: Cancer
https://read.qxmd.com/read/38702989/gedunin-modulates-cellular-growth-and-apoptosis-in-glioblastoma-cell-lines
#2
JOURNAL ARTICLE
Michael Stouffer, Elizabeth Wandling, Lindsay Dickson, Stacy Lin, Huanyun Duan, Erika Powe, Denise Jean-Louis, Amit K Tiwari, Samson Amos
BACKGROUND: Glioblastomas are characterized by aggressive behavior. Surgery, radiotherapy, and alkylating agents, including temozolomide are the most common treatment options for glioblastoma. Often, conventional therapies fail to treat these tumors since they develop drug resistance. There is a need for newer agents to combat this deadly tumor. Natural products such as gedunin have shown efficacy in several human diseases. A comprehensive study of gedunin, an heat shock protein (HSP)90 inhibitor, has not been thoroughly investigated in glioblastoma cell lines with different genetic modifications...
May 2024: Cancer reports
https://read.qxmd.com/read/38702967/exploring-the-regulatory-role-of-fbxl19-as1-in-triple-negative-breast-cancer-through-the-mir-378a-3p-otub2-axis
#3
JOURNAL ARTICLE
Chenxu Guo, Mingliang Zhang, Xin Jin, Chao Zhu, Jun Qian, Min Tao
The regulatory potential of long noncoding RNA (lncRNA) FBXL19-AS1 has been highlighted in various cancers, but its effect on triple-negative breast cancer (TNBC) remains unclear. Here, we aimed to elucidate the role of FBXL19-AS1 in TNBC and its underlying mechanism. RT-qPCR was employed to detect the expressions of FBXL19-AS1 and miR-378a-3p in tissues and cells. Immunohistochemical staining and western blot were utilized to detect the expression levels of proteins. Cell activities were detected using flow cytometry, CCK-8, and transwell assay...
June 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38702966/radioligand-therapies-in-meningioma-evidence-and-future-directions
#4
JOURNAL ARTICLE
Maximilian J Mair, Emeline Tabouret, Derek R Johnson, Erik P Sulman, Patrick Y Wen, Matthias Preusser, Nathalie L Albert
Meningiomas are the most common intracranial neoplasms in adults. While most meningiomas are cured by resection, further treatment by radiotherapy may be needed, particularly in WHO grade 2 and 3 tumors which have an increased risk of recurrence, even after conventional therapies. Still, there is an urgent need for novel therapeutic strategies after exhaustion of local treatment approaches. Radionuclide therapies combine the specificity of tumor-specific antibodies or ligands with the cytotoxic activity of radioactive emitters...
May 4, 2024: Neuro-oncology
https://read.qxmd.com/read/38702938/linc00152-potential-driver-oncogene-in-pan-cancer
#5
REVIEW
Wei Xu, Huiting Li, Ziyao Wang, Yan Kang, Luojie Zheng, Yiping Liu, Ping Xu, Zheng Li
Long noncoding RNAs (lncRNA) are a class of non-coding RNAs greater than 200 bp in length with limited peptide-coding function. The transcription of LINC00152 is derived from chromosome 2p11.2. Many studies prove that LINC00152 influences the progression of various tumors via promoting the tumor cells malignant phenotype, chemoresistance, and immune escape. LINC00152 is regulated by multiple transcription factors and DNA hypomethylation. In addition, LINC00152 participates in the regulation of complex molecular signaling networks through epigenetic regulation, protein interactions, and competitive endogenous RNA (ceRNA)...
2024: Wiley Interdisciplinary Reviews. RNA
https://read.qxmd.com/read/38702830/identification-of-tp53-germline-variants-in-pediatric-patients-undergoing-tumor-testing-strategy-and-prevalence
#6
JOURNAL ARTICLE
Minjie Luo, Derek Wong, Kristin Zelley, Jinhua Wu, Jeffery Schubert, Elizabeth H Denenberg, Elizabeth A Fanning, Jiani Chen, Daniel Gallo, Netta Golenberg, Maha Patel, Laura K Conlin, Kara N Maxwell, Gerald B Wertheim, Lea F Surrey, Yiming Zhong, Garrett M Brodeur, Suzanne P MacFarland, Marilyn M Li
BACKGROUND: TP53 alterations are common in certain pediatric cancers, making identification of putative germline variants through tumor genomic profiling crucial for patient management. METHODS: We analyzed TP53 alterations in 3123 tumors from 2788 pediatric patients sequenced using tumor-only or tumor-normal paired panels. Germline confirmatory testing was performed when indicated. Somatic and germline variants were classified following published guidelines. RESULTS: In 248 tumors from 222 patients, 284 Tier 1/2 TP53 sequence and small copy number variants were detected...
May 3, 2024: Journal of the National Cancer Institute
https://read.qxmd.com/read/38702828/comparing-niraparib-versus-platinum-taxane-doublet-chemotherapy-as-neoadjuvant-treatment-in-patients-with-newly-diagnosed-homologous-recombination-deficient-stage-iii-iv-ovarian-cancer-study-protocol-for-cohort-c-of-the-open-label-phase-2-randomized-controlled
#7
COMPARATIVE STUDY
Jimmy Belotte, Brunella Felicetti, Amanda J Baines, Ahmed YoussefAgha, Luis Rojas-Espaillat, Ana Godoy Ortiz, Diane Provencher, Raúl Márquez Vázquez, Lucia González Cortijo, Xing Zeng
BACKGROUND: Maintenance therapy with niraparib, a poly(ADP-ribose) polymerase inhibitor, has been shown to extend progression-free survival in patients with newly diagnosed advanced ovarian cancer who responded to first-line platinum-based chemotherapy, regardless of biomarker status. However, there are limited data on niraparib's efficacy and safety in the neoadjuvant setting. The objective of Cohort C of the OPAL trial (OPAL-C) is to evaluate the efficacy, safety, and tolerability of neoadjuvant niraparib treatment compared with neoadjuvant platinum-taxane doublet chemotherapy in patients with newly diagnosed stage III/IV ovarian cancer with confirmed homologous recombination-deficient tumors...
May 4, 2024: Trials
https://read.qxmd.com/read/38702822/precision-medicine-for-pancreatic-cancer-characterizing-the-clinico-genomic-landscape-and-outcomes-of-kras-g12c-mutated-disease
#8
JOURNAL ARTICLE
Fergus Keane, Joanne F Chou, Henry Walch, Joshua Schoenfeld, Anupriya Singhal, Darren Cowzer, Emily Harrold, Catherine O'Connor, Wungki Park, Anna Varghese, Imane El Dika, Fiyinfolu Balogun, Kenneth H Yu, Marinela Capanu, Nikolaus Schultz, Rona Yaeger, Eileen M O'Reilly
BACKGROUND: Mutated KRAS is the most common oncogene alteration in pancreatic cancer (PDAC), and KRAS G12C mutations (KRAS G12Cmut) are observed in 1-2%. Several inhibitors of KRAS G12C have recently demonstrated promise in solid tumors, including PDAC. Little is known regarding clinical, genomics and outcome data of this population. METHODS: Patients with PDAC and KRAS G12Cmut were identified at Memorial Sloan Kettering Cancer Center (MSK), and via the AACR Project GENIE database...
May 3, 2024: Journal of the National Cancer Institute
https://read.qxmd.com/read/38702821/head-to-head-comparison-of-68-ga-ga-dota-fapi-04-and-18-f-fdg-pet-ct-for-the-evaluation-of-tonsil-cancer-and-lymph-node-metastases-a-single-centre-retrospective-study
#9
COMPARATIVE STUDY
Mengjing Ji, Guang Ma, Cheng Liu, Bingxin Gu, Xinyue Du, Xiaomin Ou, Xiaoping Xu, Shaoli Song, Zhongyi Yang
BACKGROUND: This study aimed to compare the diagnostic value of [68  Ga]Ga-DOTA-FAPI-04 and [18 F]FDG PET/CT imaging for primary lesions and metastatic lymph nodes in patients with tonsil cancer. METHOD: Twenty-one tonsil cancer patients who underwent [68  Ga]Ga-DOTA-FAPI-04 and [18 F]FDG PET/CT scans within two weeks in our centre were retrospectively enrolled. The maximum standardized uptake value (SUVmax) and tumor-to-background ratio (TBR) of the two tracers were compared by using the Mann‒Whitney U test...
May 3, 2024: Cancer Imaging: the Official Publication of the International Cancer Imaging Society
https://read.qxmd.com/read/38702814/integrative-analyses-of-bulk-and-single-cell-transcriptomics-reveals-the-infiltration-and-crosstalk-of-cancer-associated-fibroblasts-as-a-novel-predictor-for-prognosis-and-microenvironment-remodeling-in-intrahepatic-cholangiocarcinoma
#10
JOURNAL ARTICLE
Yan-Jie Zhong, Xi-Mei Luo, Fei Liu, Zhi-Qiang He, Si-Qi Yang, Wen-Jie Ma, Jun-Ke Wang, Yu-Shi Dai, Rui-Qi Zou, Ya-Fei Hu, Tian-Run Lv, Fu-Yu Li, Hai-Jie Hu
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is a highly malignant neoplasm and characterized by desmoplastic matrix. The heterogeneity and crosstalk of tumor microenvironment remain incompletely understood. METHODS: To address this gap, we performed Weighted Gene Co-expression Network Analysis (WGCNA) to identify and construct a cancer associated fibroblasts (CAFs) infiltration biomarker. We also depicted the intercellular communication network and important receptor-ligand complexes using the single-cell transcriptomics analysis of tumor and Adjacent normal tissue...
May 3, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38702792/the-deubiquitinase-usp7-and-e3-ligase-trim21-regulate-vasculogenic-mimicry-and-malignant-progression-of-rms-by-balancing-snai2-homeostasis
#11
JOURNAL ARTICLE
Ruyue Zhang, Daidi Zhang, Fugen Han, Xiaorui Song, Yaodong Zhang, Jie Zhang, Qingwen Zhu, Yanru Qin
BACKGROUND: Rhabdomyosarcoma (RMS) is a rare malignancy and the most common soft tissue sarcoma in children. Vasculogenic mimicry (VM) is a novel tumor microcirculation model different from traditional tumor angiogenesis, which does not rely on endothelial cells to provide sufficient blood supply for tumor growth. In recent years, VM has been confirmed to be closely associated with tumor progression. However, the ability of RMS to form VM has not yet been reported. METHODS: Immunohistochemistry, RT-qPCR and western blot were used to test the expression level of SNAI2 and its clinical significance...
May 4, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38702787/characterizing-oxphos-inhibitor-mediated-alleviation-of-hypoxia-using-high-throughput-live-cell-imaging
#12
JOURNAL ARTICLE
Anne P M Beerkens, Daan F Boreel, James A Nathan, Jiri Neuzil, Gang Cheng, Balaraman Kalyanaraman, Micael Hardy, Gosse J Adema, Sandra Heskamp, Paul N Span, Johan Bussink
BACKGROUND: Hypoxia is a common feature of many solid tumors and causes radiotherapy and immunotherapy resistance. Pharmacological inhibition of oxidative phosphorylation (OXPHOS) has emerged as a therapeutic strategy to reduce hypoxia. However, the OXPHOS inhibitors tested in clinical trials caused only moderate responses in hypoxia alleviation or trials were terminated due to dose-limiting toxicities. To improve the therapeutic benefit, FDA approved OXPHOS inhibitors (e.g. atovaquone) were conjugated to triphenylphosphonium (TPP+ ) to preferentially target cancer cell's mitochondria...
May 3, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38702757/a-comprehensive-examination-of-mental-health-in-patients-with-head-and-neck-cancer-systematic-review-and-meta-analysis
#13
JOURNAL ARTICLE
Pablo Jimenez-Labaig, Claudia Aymerich, Irene Braña, Antonio Rullan, Jon Cacicedo, Miguel Ángel González-Torres, Kevin J Harrington, Ana Catalan
BACKGROUND: Patients with head and neck cancer (HNC) present particularly significant levels of emotional distress. However, the actual rates of clinically relevant mental health symptoms and disorders among this population remain unknown. METHODS: A PRISMA/MOOSE-compliant systematic review and quantitative random-effects meta-analysis was performed to determine suicide incidence and the prevalence of depression, anxiety, distress, post-traumatic stress, and insomnia in this population...
May 3, 2024: JNCI Cancer Spectrum
https://read.qxmd.com/read/38702718/signaling-cancer-cell-plasticity-and-intratumor-heterogeneity
#14
EDITORIAL
Marco Cordani, Ilaria Dando, Giulia Ambrosini, Pedro González-Menéndez
Cancer's complexity is in part due to the presence of intratumor heterogeneity and the dynamic nature of cancer cell plasticity, which create substantial obstacles in effective cancer management. Variability within a tumor arises from the existence of diverse populations of cancer cells, impacting the progression, spread, and resistance to treatments. At the core of this variability is the concept of cellular plasticity - the intrinsic ability of cancer cells to alter their molecular and cellular identity in reaction to environmental and genetic changes...
May 3, 2024: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/38702709/a-mitochondrion-targeted%C3%A2-cyanine-agent-for-nir-ii-fluorescence-guided-surgery-combined-with-intraoperative-photothermal-therapy-to-reduce-prostate-cancer-recurrence
#15
JOURNAL ARTICLE
Chenchen Liu, Zong Chang, Kailei Chen, Qiang Xue, Bingxin Shu, Zhihao Wei, Xuan Zhou, Like Guo, Yuling Zhang, Yingying Pan, Qi Cao, Huageng Liang, Qinchao Sun, Xiaoping Zhang
Poorly identified tumor boundaries and nontargeted therapies lead to the high recurrence rates and poor quality of life of prostate cancer patients. Near-infrared-II (NIR-II) fluorescence imaging provides certain advantages, including high resolution and the sensitive detection of tumor boundaries. Herein, a cyanine agent (CY7-4) with significantly greater tumor affinity and blood circulation time than indocyanine green was screened. By binding albumin, the absorbance of CY7-4 in an aqueous solution showed no effects from aggregation, with a peak absorbance at 830 nm and a strong fluorescence emission tail beyond 1000 nm...
May 3, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38702698/identification-of-prognostic-stemness-related-genes-in-kidney-renal-papillary-cell-carcinoma
#16
JOURNAL ARTICLE
Yifan Liu, Yuntao Yao, Yu Zhang, Chengdang Xu, Tianyue Yang, Mingyu Qu, Bingnan Lu, Xu Song, Xiuwu Pan, Wang Zhou, Xingang Cui
BACKGROUND: Kidney renal papillary cell carcinoma (KIRP) is the second most prevalent malignant cancer originating from the renal epithelium. Nowadays, cancer stem cells and stemness-related genes (SRGs) are revealed to play important roles in the carcinogenesis and metastasis of various tumors. Consequently, we aim to investigate the underlying mechanisms of SRGs in KIRP. METHODS: RNA-seq profiles of 141 KIRP samples were downloaded from the TCGA database, based on which we calculated the mRNA expression-based stemness index (mRNAsi)...
May 3, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38702684/histology-specific-standardized-incidence-ratio-improves-the-estimation-of-second-primary-lung-cancer-risk
#17
JOURNAL ARTICLE
Marian Eberl, Luana F Tanaka, Klaus Kraywinkel, Stefanie J Klug
BACKGROUND: Lung cancer (LC) survivors are at increased risk for developing a second primary cancer (SPC) compared to the general population. While this risk is particularly high for smoking-related SPCs, the published standardized incidence ratio (SIR) for lung cancer after lung cancer is unexpectedly low in countries that follow international multiple primary (IARC/IACR MP) rules when compared to the USA, where distinct rules are employed. IARC/IACR rules rely on histology-dependent documentation of SPC with the same location as the first cancer and only classify an SPC when tumors present different histology...
May 3, 2024: BMC Medicine
https://read.qxmd.com/read/38702677/analyzing-the-expression-and-clinical-significance-of-cenpe-in-gastric-cancer
#18
JOURNAL ARTICLE
Jing Wang, Xiaofei Li, Xihui Qiang, Xueqing Yin, Lianyi Guo
BACKGROUND: Gastric cancer (GC) is a prevalent type of malignant gastrointestinal tumor. Many studies have shown that CENPE acts as an oncogene in some cancers. However, its expression level and clinical value in GC are not clear. METHODS: Obtaining clinical data information on gastric adenocarcinoma from TCGA and GEO databases. The gene expression profiling interaction analysis (GEPIA) was used to evaluate the relationship between prognosis and CENPE expression in gastric cancer patients...
May 3, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38702645/long-term-survival-after-hepatic-resection-for-colorectal-liver-metastases-a-single-center-study-in-iran
#19
JOURNAL ARTICLE
Seyed Morteza Pourfaraji, Mehdi Nazari Moghadam, Ali Mohammad Moradi, Fatemeh Ojaghi Shirmard, Narjes Mohammadzadeh, Ali Jafarian
BACKGROUND: Surgical resection of colorectal cancer liver metastasis (CRLM) has been associated with improved survival in these patients. The purpose of this study was to investigate the usefulness of liver metastasectomy, also finding independent factors related to survival after liver metastasectomy. METHODS: In a retrospective study, all patients with CRLM who underwent resection of liver metastases between 2012 and 2022 at Imam Khomeini Hospital Complex in Tehran, Iran, were enrolled...
May 3, 2024: BMC Surgery
https://read.qxmd.com/read/38702644/muc1-promotes-cervical-squamous-cell-carcinoma-through-erk-phosphorylation-mediated-regulation-of-itga2-itga3
#20
JOURNAL ARTICLE
Aiqin Zhao, Yunzhi Pan, Yingyin Gao, Zheng Zhi, Haiying Lu, Bei Dong, Xuan Zhang, Meiying Wu, Fenxia Zhu, Sufang Zhou, Sai Ma
In contrast to the decreasing trends in developed countries, the incidence and mortality rates of cervical squamous cell carcinoma in China have increased significantly. The screening and identification of reliable biomarkers and candidate drug targets for cervical squamous cell carcinoma are urgently needed to improve the survival rate and quality of life of patients. In this study, we demonstrated that the expression of MUC1 was greater in neoplastic tissues than in non-neoplastic tissues of the cervix, and cervical squamous cell carcinoma patients with high MUC1 expression had significantly worse overall survival than did those with low MUC1 expression, indicating its potential for early diagnosis of cervical squamous cell carcinoma...
May 3, 2024: BMC Cancer
keyword
keyword
83534
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.